奧比中光(688322.SH):公司的3D人臉識別技術,目前主要應用於3D刷臉支付等領域
格隆匯10月16日丨奧比中光(688322.SH)在10月13日投資者關係活動上表示,今年以來,伴隨着各省市國家醫保專網相繼落地商用,眾多適配公司模組的醫保終端也陸續上線;除提供3D攝像頭模組,公司在此領域的整機設備產品也實現了從0到1的落地,並已為部分醫保終端廠家提供刷臉PAD,為後續大規模出貨奠定了堅實基礎。隨着越來越多項目形成的良好示範效應,將加快醫保場景應用的落地,助力公司生物識別業務線的加速拓展。隨着對於身份識別和保密需求的日益增加,各類新興生物識別的技術不斷髮展,通過3D視覺感知技術實現的生物識別方法逐漸落地於不同的應用場景。如公司的3D人臉識別技術,目前主要應用於3D刷臉支付、智能門鎖/門禁及醫保核身等領域。同時,公司持續加大市場推廣力度,穩步推進3D視覺傳感器在線下零售、自助貨櫃、餐飲、醫療、校園、景區、酒店等支付場景的應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.